(BAH) Booz Allen Hamilton Holding - Ratings and Ratios
AI Solutions, Cyber Solutions, Cloud Migration, Quantum Sciences
BAH EPS (Earnings per Share)
BAH Revenue
Description: BAH Booz Allen Hamilton Holding October 30, 2025
Booz Allen Hamilton Holding Corporation (NYSE: BAH) is a veteran technology and consulting firm that delivers AI-driven, cyber, and cloud-enabled solutions to U.S. cabinet-level agencies and commercial clients worldwide. Its portfolio spans purpose-built artificial-intelligence applications, cyber-defense services, legacy-system modernization, multi-modal data-fusion for ISR and battle-management, as well as emerging quantum information sciences-including quantum computing, sensing, communications, and post-quantum cryptography.
Key operating metrics highlight the firm’s scale and growth trajectory: FY 2023 revenue topped $8.1 billion, with a backlog exceeding $10 billion, indicating strong forward-order flow. AI-related services grew roughly 15 % year-over-year, outpacing the broader IT-consulting sector, while federal IT spending is projected to rise 4-5 % annually through 2028, providing a tailwind for BAH’s government contracts. Additionally, the company’s quantum-technology unit, launched in 2022, has already secured three multi-year DoD research agreements, positioning it to capture early market share as post-quantum standards evolve.
If you’re looking for a data-driven, quantitative assessment of BAH’s valuation, a quick dive into ValueRay’s analytics platform could provide the deeper insight you need.
BAH Stock Overview
| Market Cap in USD | 12,361m |
| Sub-Industry | IT Consulting & Other Services |
| IPO / Inception | 2010-11-17 |
BAH Stock Ratings
| Growth Rating | -28.3% |
| Fundamental | 79.2% |
| Dividend Rating | 67.5% |
| Return 12m vs S&P 500 | -59.9% |
| Analyst Rating | 3.50 of 5 |
BAH Dividends
| Dividend Yield 12m | 2.48% |
| Yield on Cost 5y | 2.90% |
| Annual Growth 5y | 13.25% |
| Payout Consistency | 88.3% |
| Payout Ratio | 33.5% |
BAH Growth Ratios
| Growth Correlation 3m | -88.1% |
| Growth Correlation 12m | -83.2% |
| Growth Correlation 5y | 80.9% |
| CAGR 5y | -5.05% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.09 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.32 |
| Sharpe Ratio 12m | -0.29 |
| Alpha | -61.99 |
| Beta | 0.414 |
| Volatility | 56.18% |
| Current Volume | 3464.1k |
| Average Volume 20d | 1727.5k |
| Stop Loss | 83.1 (-4.7%) |
| Signal | 0.33 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (823.7m TTM) > 0 and > 6% of Revenue (6% = 702.3m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -1.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.85% (prev 9.12%; Δ 2.73pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 909.8m > Net Income 823.7m (YES >=105%, WARN >=100%) |
| Net Debt (-532.0m) to EBITDA (1.19b) ratio: -0.45 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (123.2m) change vs 12m ago -4.35% (target <= -2.0% for YES) |
| Gross Margin 53.45% (prev 54.77%; Δ -1.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 166.9% (prev 166.2%; Δ 0.69pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.31 (EBITDA TTM 1.19b / Interest Expense TTM 193.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.37
| (A) 0.19 = (Total Current Assets 3.22b - Total Current Liabilities 1.83b) / Total Assets 7.15b |
| (B) 0.47 = Retained Earnings (Balance) 3.38b / Total Assets 7.15b |
| (C) 0.15 = EBIT TTM 1.03b / Avg Total Assets 7.02b |
| (D) 0.54 = Book Value of Equity 3.35b / Total Liabilities 6.16b |
| Total Rating: 4.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 79.16
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 6.92% = 3.46 |
| 3. FCF Margin 7.00% = 1.75 |
| 4. Debt/Equity 0.29 = 2.46 |
| 5. Debt/Ebitda -0.45 = 2.50 |
| 6. ROIC - WACC (= 8.19)% = 10.23 |
| 7. RoE 77.09% = 2.50 |
| 8. Rev. Trend 83.53% = 6.26 |
| 9. EPS Trend -20.19% = -1.01 |
What is the price of BAH shares?
Over the past week, the price has changed by +0.73%, over one month by -15.47%, over three months by -21.39% and over the past year by -51.39%.
Is Booz Allen Hamilton Holding a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BAH is around 64.71 USD . This means that BAH is currently overvalued and has a potential downside of -25.76%.
Is BAH a buy, sell or hold?
- Strong Buy: 4
- Buy: 1
- Hold: 7
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the BAH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 124.2 | 42.5% |
| Analysts Target Price | 124.2 | 42.5% |
| ValueRay Target Price | 71.6 | -17.8% |
BAH Fundamental Data Overview October 25, 2025
P/E Trailing = 12.3206
P/E Forward = 16.5289
P/S = 1.0333
P/B = 11.9326
P/EG = 2.29
Beta = 0.414
Revenue TTM = 11.71b USD
EBIT TTM = 1.03b USD
EBITDA TTM = 1.19b USD
Long Term Debt = 3.92b USD (from longTermDebt, last fiscal year)
Short Term Debt = 124.0m USD (from shortTermDebt, last quarter)
Debt = 284.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -532.0m USD (from netDebt column, last quarter)
Enterprise Value = 11.83b USD (12.36b + Debt 284.0m - CCE 816.0m)
Interest Coverage Ratio = 5.31 (Ebit TTM 1.03b / Interest Expense TTM 193.9m)
FCF Yield = 6.92% (FCF TTM 819.0m / Enterprise Value 11.83b)
FCF Margin = 7.00% (FCF TTM 819.0m / Revenue TTM 11.71b)
Net Margin = 7.04% (Net Income TTM 823.7m / Revenue TTM 11.71b)
Gross Margin = 53.45% ((Revenue TTM 11.71b - Cost of Revenue TTM 5.45b) / Revenue TTM)
Gross Margin QoQ = 53.63% (prev 51.33%)
Tobins Q-Ratio = 1.65 (Enterprise Value 11.83b / Total Assets 7.15b)
Interest Expense / Debt = 16.90% (Interest Expense 48.0m / Debt 284.0m)
Taxrate = 24.89% (58.0m / 233.0m)
NOPAT = 772.5m (EBIT 1.03b * (1 - 24.89%))
Current Ratio = 1.76 (Total Current Assets 3.22b / Total Current Liabilities 1.83b)
Debt / Equity = 0.29 (Debt 284.0m / totalStockholderEquity, last quarter 996.0m)
Debt / EBITDA = -0.45 (Net Debt -532.0m / EBITDA 1.19b)
Debt / FCF = -0.65 (Net Debt -532.0m / FCF TTM 819.0m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.51% (Net Income 823.7m / Total Assets 7.15b)
RoE = 77.09% (Net Income TTM 823.7m / Total Stockholder Equity 1.07b)
RoCE = 20.64% (EBIT 1.03b / Capital Employed (Equity 1.07b + L.T.Debt 3.92b))
RoIC = 15.84% (NOPAT 772.5m / Invested Capital 4.88b)
WACC = 7.66% (E(12.36b)/V(12.64b) * Re(7.54%) + D(284.0m)/V(12.64b) * Rd(16.90%) * (1-Tc(0.25)))
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.82%
[DCF Debug] Terminal Value 76.27% ; FCFE base≈860.0m ; Y1≈757.0m ; Y5≈622.2m
Fair Price DCF = 91.66 (DCF Value 11.30b / Shares Outstanding 123.2m; 5y FCF grow -14.70% → 3.0% )
EPS Correlation: -20.19 | EPS CAGR: -54.41% | SUE: -4.0 | # QB: 0
Revenue Correlation: 83.53 | Revenue CAGR: 9.05% | SUE: -1.16 | # QB: 0
Additional Sources for BAH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle